Literature DB >> 818334

Nonspecific complement activation by streptococcal structures. I. Re-evaluation of HLA cytotoxicity inhibition.

J W Tauber, J A Falk, R E Falk, J B Zabriskie.   

Abstract

A number of experiments have suggested that there is an antigenic relationship between the HLA complex and streptococcal bacterial structures. Using inhibition of cytotoxicity of HLA antisera as our assay system, it was demonstrated that the inhibitory effect on HLA cytotoxicity by streptococcal antigens is, in reality, due to activation and consumption of components of the alternate complement pathway. In addition, antisera prepared against streptococcal membrane antigens had no cytotoxic effect on a large panel of human lymphocytes, nor did these antisera exhibit immunofluorescent staining of lymphocytes directly. These experiments are compatible with our concept that the HLA complex may have evolved through selective evolutionary pressure as a means of escaping bacterial mimicry.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 818334      PMCID: PMC2190213          DOI: 10.1084/jem.143.6.1341

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

1.  IMPROVED TECHNIQUE FOR THE PREPARATION OF STREPTOCOCCAL CELL WALLS.

Authors:  A S BLEIWEIS; W W KARAKAWA; R M KRAUSE
Journal:  J Bacteriol       Date:  1964-10       Impact factor: 3.490

2.  HOMOGRAFT SENSITIVITY INDUCTION BY GROUP A STREPTOCOCCI.

Authors:  F T RAPAPORT; R M CHASE
Journal:  Science       Date:  1964-07-24       Impact factor: 47.728

3.  MICRODROPLET ASSAY OF HUMAN SERUM CYTOTOXINS.

Authors:  P I TERASAKI; J D MCCLELLAND
Journal:  Nature       Date:  1964-12-05       Impact factor: 49.962

4.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  Rejection of skin allografts by irradiation chimeras: evidence for skin-specific transplantation barrier.

Authors:  E M Lance; E A Boyse; S Cooper; E A Carswell
Journal:  Transplant Proc       Date:  1971-03       Impact factor: 1.066

6.  Cross-reactions between streptococcal M proteins and human transplantation antigens.

Authors:  A A Hirata; P I Terasaki
Journal:  Science       Date:  1970-05-29       Impact factor: 47.728

7.  In vitro detection of transplantation immunity: the inhibition of migration of immune spleen cells and peripheral blood leukocytes by specific antigen.

Authors:  R E Falk; L Collste; G Möller
Journal:  J Immunol       Date:  1970-05       Impact factor: 5.422

8.  Nonspecific complement activation by streptococcal structures. II. Properdin-independent initiation of the alternate pathway.

Authors:  J W Tauber; M J Polley; J B Zabriskie
Journal:  J Exp Med       Date:  1976-06-01       Impact factor: 14.307

9.  Purification and physical properties of group C streptococcal phage-associated lysin.

Authors:  V A Fischetti; E C Gotschlich; A W Bernheimer
Journal:  J Exp Med       Date:  1971-05-01       Impact factor: 14.307

10.  Studies of L forms and protoplasts of group A streptococci. I. Isolation, growth, and bacteriologic characteristics.

Authors:  E H FREIMER; R M KRAUSE; M McCARTY
Journal:  J Exp Med       Date:  1959-12-01       Impact factor: 14.307

  10 in total
  3 in total

1.  Complement activating factor(s) of Trypanosoma lewisi: some physiochemical characteristics of the active components.

Authors:  K Nielsen; J Sheppard; I Tizard; W Holmes
Journal:  Can J Comp Med       Date:  1978-01

2.  Activation of the alternative pathway of complement by Malassezia ovalis (Pityrosporum ovale).

Authors:  P W Belew; E W Rosenberg; B R Jennings
Journal:  Mycopathologia       Date:  1980-03-31       Impact factor: 2.574

3.  Nonspecific complement activation by streptococcal structures. II. Properdin-independent initiation of the alternate pathway.

Authors:  J W Tauber; M J Polley; J B Zabriskie
Journal:  J Exp Med       Date:  1976-06-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.